About the Addiction Psychiatry Division

Focus of the Addiction Psychiatry Division

The Division on Addiction Psychiatry provides an integrated program that includes research, education, and clinical care for addictive disorders. The Division nurtures a continuum of research, education, and patient care from basic neurobiological mechanisms to the latest clinical advances in addiction treatment. The Division works collaboratively with members of the Psychiatry Department, other departments within UT Southwestern Medical Center, and with community partners to promote a deeper understanding of addictive disorders, enhance professional development, establish and facilitate community research efforts, and improve treatment outcomes.

Addiction Psychiatry Division Leadership

Division Chief Bryon Adinoff, M.D., holds the Distinguished Professorship in Alcohol and Drug Abuse Research. He is also a Professor and a staff psychiatrist at the Dallas Veterans Affairs Medical Center. He has published more than 100 articles and chapters on the biology and treatment of addiction. Dr. Adinoff has had research studies funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) the National Institute of Drug Abuse (NIDA), and the Department of Veterans Affairs.

Involvement in Education & Training

The Division of Addiction Psychiatry provides several formal training opportunities, including an Addiction Psychiatry Fellowship and a Clinical Research Training Program in Addiction Psychiatry. The Division also participates in addiction research programs for medical, postdoctoral, and undergraduate students. 

Involvement in Research

The Division of Addiction Psychiatry encompasses multiple laboratories performing preclinical and clinical studies in addictions. These studies span addictive disorders ranging from substances of abuse (including cocaine, amphetamine, opioids, and alcohol) to natural rewarding substances (including highly palatable foods and, more recently, UV light in tanners). By utilizing cross-translational approaches to inform our preclinical and clinical laboratories, our Division is able to capitalize on their mutual strengths and incorporate shared approaches from molecular to treatment outcome studies. 

Involvement in Patient Care

As the Texas Node of the NIDA Clinical Trials Network, the Division of Addiction Psychiatry works with community treatment centers to evaluate the effectiveness of behavioral and pharmacological therapies in real-world settings. These centers serve people from a broad range of sociodemographic backgrounds and with a wide variety of addictions and co-morbidities.

To maximize the program, the Division will:

  • Promote translational research in addictive disorders by fostering collaboration between researchers, educators, and clinicians in order to further two-way “bench to bedside” sharing of information (from basic and clinical research to patient care and back).
  • Educate future clinicians and researchers in the addictive disorders.
  • Disseminate evidence-based practices to community treatment providers in order to inform and improve treatment outcomes.
  • Develop and maintain a website to advance communication and collaboration among the Division’s academic faculty and to serve as a resource for both treatment providers and the lay community.